| 1 | variability | 7,329 |
| 2 | fluctuation | 414 |
| 3 | variances | 240 |
| 4 | turbulence | 112 |
| 5 | variabilities | 70 |
| 6 | covariances | 17 |
| 7 | reproducibilities | 11 |
| 8 | in-range | 7 |
| 9 | enantiopurity | 3 |
| 10 | jejuno-jejunostomy | 3 |
| 11 | over-dispensing | 3 |
| 12 | 80-120/min | 2 |
| 13 | perforation/tm | 2 |
| 14 | prefactor | 2 |
| 15 | racecadotril/placebo | 2 |
| 16 | ≥108 | 2 |
| 17 | 0/93 | 1 |
| 18 | 1+aℓ | 1 |
| 19 | 10-20mg/h | 1 |
| 20 | 107/1737 | 1 |
| 21 | 110/minute | 1 |
| 22 | 135/969 | 1 |
| 23 | 14/308 | 1 |
| 24 | 140/80mm/hg | 1 |
| 25 | 164.7±17.1/92.3±12.2mmhg | 1 |
| 26 | 1690/s | 1 |
| 27 | 2/249 | 1 |
| 28 | 25/s | 1 |
| 29 | 264±191 | 1 |
| 30 | 3-joint | 1 |
| 31 | 3/s | 1 |
| 32 | 36/min | 1 |
| 33 | 5.76-fold | 1 |
| 34 | 5/249 | 1 |
| 35 | =0.029 | 1 |
| 36 | =0.277 | 1 |
| 37 | balance-preserving | 1 |
| 38 | baroresponse | 1 |
| 39 | bis-amine | 1 |
| 40 | case-counselling | 1 |
| 41 | changes.results | 1 |
| 42 | colonization-infection | 1 |
| 43 | competition-driven | 1 |
| 44 | control-by | 1 |
| 45 | crossover-study | 1 |
| 46 | delta=-27.2+/-3.9 | 1 |
| 47 | diastolic/pep | 1 |
| 48 | difference/mean | 1 |
| 49 | filtration-based | 1 |
| 50 | gc-clamp | 1 |
| 51 | genotype-by-genotype | 1 |
| 52 | hovers | 1 |
| 53 | interval=2.6 | 1 |
| 54 | monitor-bcm | 1 |
| 55 | n-busn | 1 |
| 56 | oflevonorgestrel | 1 |
| 57 | paclitaxel/epirubicin/carboplatin | 1 |
| 58 | preece-baines | 1 |
| 59 | protocol.seventy-five | 1 |
| 60 | ratio=.49 | 1 |
| 61 | ratio=0.28 | 1 |
| 62 | ratio=0·77 | 1 |
| 63 | ratio=1.02 | 1 |
| 64 | ratio=2.23 | 1 |
| 65 | ratio=4.8 | 1 |
| 66 | ratio=5.39 | 1 |
| 67 | ratios.we | 1 |
| 68 | re-monitoring | 1 |
| 69 | reserve= | 1 |
| 70 | response-differences | 1 |
| 71 | school-quality | 1 |
| 72 | severe/nocturnal/severe | 1 |
| 73 | strain-relatedness | 1 |
| 74 | strength-differences | 1 |
| 75 | variability- | 1 |
| 76 | variability-biofeedback | 1 |
| 77 | variability-cv | 1 |
| 78 | vdsr | 1 |
| 79 | ∼157/86 | 1 |
| 1 | 0/93 | 1 |
| 2 | 1+aℓ | 1 |
| 3 | 10-20mg/h | 1 |
| 4 | 107/1737 | 1 |
| 5 | 110/minute | 1 |
| 6 | 135/969 | 1 |
| 7 | 14/308 | 1 |
| 8 | 140/80mm/hg | 1 |
| 9 | 164.7±17.1/92.3±12.2mmhg | 1 |
| 10 | 1690/s | 1 |
| 11 | 2/249 | 1 |
| 12 | 25/s | 1 |
| 13 | 264±191 | 1 |
| 14 | 3-joint | 1 |
| 15 | 3/s | 1 |
| 16 | 36/min | 1 |
| 17 | 5.76-fold | 1 |
| 18 | 5/249 | 1 |
| 19 | 80-120/min | 2 |
| 20 | =0.029 | 1 |
| 21 | =0.277 | 1 |
| 22 | balance-preserving | 1 |
| 23 | baroresponse | 1 |
| 24 | bis-amine | 1 |
| 25 | case-counselling | 1 |
| 26 | changes.results | 1 |
| 27 | colonization-infection | 1 |
| 28 | competition-driven | 1 |
| 29 | control-by | 1 |
| 30 | covariances | 17 |
| 31 | crossover-study | 1 |
| 32 | delta=-27.2+/-3.9 | 1 |
| 33 | diastolic/pep | 1 |
| 34 | difference/mean | 1 |
| 35 | enantiopurity | 3 |
| 36 | filtration-based | 1 |
| 37 | fluctuation | 414 |
| 38 | gc-clamp | 1 |
| 39 | genotype-by-genotype | 1 |
| 40 | hovers | 1 |
| 41 | in-range | 7 |
| 42 | interval=2.6 | 1 |
| 43 | jejuno-jejunostomy | 3 |
| 44 | monitor-bcm | 1 |
| 45 | n-busn | 1 |
| 46 | oflevonorgestrel | 1 |
| 47 | over-dispensing | 3 |
| 48 | paclitaxel/epirubicin/carboplatin | 1 |
| 49 | perforation/tm | 2 |
| 50 | preece-baines | 1 |
| 51 | prefactor | 2 |
| 52 | protocol.seventy-five | 1 |
| 53 | racecadotril/placebo | 2 |
| 54 | ratio=.49 | 1 |
| 55 | ratio=0.28 | 1 |
| 56 | ratio=0·77 | 1 |
| 57 | ratio=1.02 | 1 |
| 58 | ratio=2.23 | 1 |
| 59 | ratio=4.8 | 1 |
| 60 | ratio=5.39 | 1 |
| 61 | ratios.we | 1 |
| 62 | re-monitoring | 1 |
| 63 | reproducibilities | 11 |
| 64 | reserve= | 1 |
| 65 | response-differences | 1 |
| 66 | school-quality | 1 |
| 67 | severe/nocturnal/severe | 1 |
| 68 | strain-relatedness | 1 |
| 69 | strength-differences | 1 |
| 70 | turbulence | 112 |
| 71 | variabilities | 70 |
| 72 | variability | 7,329 |
| 73 | variability- | 1 |
| 74 | variability-biofeedback | 1 |
| 75 | variability-cv | 1 |
| 76 | variances | 240 |
| 77 | vdsr | 1 |
| 78 | ∼157/86 | 1 |
| 79 | ≥108 | 2 |
| 1 | variability- | 1 |
| 2 | 264±191 | 1 |
| 3 | ratio=1.02 | 1 |
| 4 | ratio=2.23 | 1 |
| 5 | 0/93 | 1 |
| 6 | interval=2.6 | 1 |
| 7 | ∼157/86 | 1 |
| 8 | 107/1737 | 1 |
| 9 | =0.277 | 1 |
| 10 | ratio=0·77 | 1 |
| 11 | ratio=4.8 | 1 |
| 12 | ≥108 | 2 |
| 13 | 14/308 | 1 |
| 14 | ratio=0.28 | 1 |
| 15 | delta=-27.2+/-3.9 | 1 |
| 16 | =0.029 | 1 |
| 17 | ratio=5.39 | 1 |
| 18 | ratio=.49 | 1 |
| 19 | 2/249 | 1 |
| 20 | 5/249 | 1 |
| 21 | 135/969 | 1 |
| 22 | reserve= | 1 |
| 23 | filtration-based | 1 |
| 24 | 5.76-fold | 1 |
| 25 | turbulence | 112 |
| 26 | in-range | 7 |
| 27 | bis-amine | 1 |
| 28 | genotype-by-genotype | 1 |
| 29 | severe/nocturnal/severe | 1 |
| 30 | baroresponse | 1 |
| 31 | 110/minute | 1 |
| 32 | protocol.seventy-five | 1 |
| 33 | ratios.we | 1 |
| 34 | 140/80mm/hg | 1 |
| 35 | 164.7±17.1/92.3±12.2mmhg | 1 |
| 36 | case-counselling | 1 |
| 37 | re-monitoring | 1 |
| 38 | over-dispensing | 3 |
| 39 | balance-preserving | 1 |
| 40 | 10-20mg/h | 1 |
| 41 | variability-biofeedback | 1 |
| 42 | oflevonorgestrel | 1 |
| 43 | monitor-bcm | 1 |
| 44 | perforation/tm | 2 |
| 45 | difference/mean | 1 |
| 46 | competition-driven | 1 |
| 47 | 80-120/min | 2 |
| 48 | 36/min | 1 |
| 49 | paclitaxel/epirubicin/carboplatin | 1 |
| 50 | fluctuation | 414 |
| 51 | colonization-infection | 1 |
| 52 | n-busn | 1 |
| 53 | racecadotril/placebo | 2 |
| 54 | diastolic/pep | 1 |
| 55 | gc-clamp | 1 |
| 56 | prefactor | 2 |
| 57 | vdsr | 1 |
| 58 | 1690/s | 1 |
| 59 | 3/s | 1 |
| 60 | 25/s | 1 |
| 61 | variances | 240 |
| 62 | covariances | 17 |
| 63 | response-differences | 1 |
| 64 | strength-differences | 1 |
| 65 | variabilities | 70 |
| 66 | reproducibilities | 11 |
| 67 | preece-baines | 1 |
| 68 | hovers | 1 |
| 69 | strain-relatedness | 1 |
| 70 | changes.results | 1 |
| 71 | 3-joint | 1 |
| 72 | variability-cv | 1 |
| 73 | control-by | 1 |
| 74 | crossover-study | 1 |
| 75 | jejuno-jejunostomy | 3 |
| 76 | school-quality | 1 |
| 77 | variability | 7,329 |
| 78 | enantiopurity | 3 |
| 79 | 1+aℓ | 1 |